INS and diabetes mellitus: Several studies in mice and rats have associated miR-29c-3p dysregulation with impaired glucose transporter expression and glycemic control in skeletal muscle, exacerbated vascular remodeling, and hepatic negative regulation of insulin signaling in diabetes [59,60,61,62].